EUVIMEDEUVIMED entdecken
Open Access

Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles

Roxana G Vitale iD, Sybren de Hoog, Frida Stock, Chelsea Scudder, Sherin E Shahegh, Chioma I Aneke, Ali Tolooe, Kevin P Fennelly, Michail S Lionakis, June Kwon-Chung, Amir Seyedmousavi iD

Medical Mycology · 2025

DOI: 10.1093/mmy/myaf072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Roxana G Vitale und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Antifungal Agents, Fungi, Mycoses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanized fungi have occasionally been identified as causative agents of severe phaeohyphomycoses, chromoblastomycosis, and mycetoma. In a retrospective study conducted from January 2012 to December 2022, a total of 133 melanized fungi were isolated from hospitalized patients at the NIH Clinical Center, both with and without known underlying predisposing factors. Isolate identification was based on phenotypic characteristics, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF MS), and PCR sequencing of the rDNA internal transcribed spacer (ITS) region. Members of the black yeast order Chaetothyriales were the most prevalent (40, 30%), predominantly Exophiala dermatitidis (30/40, 75%). Other major groups included: Capnodiales (30, 22.6%), Pleosporales (24, 18%), Mycosphaerellales (19, 14.3%), Calosphaeriales (8, 6%), and Venturiales (7, 5.3%). MALDI-ToF often failed to accurately identify the isolates, except for E. dermatitidis, which yielded scores ≥2. ITS sequencing was effective in accurately identifying the melanized fungi encountered in clinical settings. Antifungal susceptibility testing against eight antifungal agents showed that azoles, micafungin, and terbinafine exhibited in vitro activity against most isolates. In contrast, olorofim and amphotericin B were less effective. Notably, Phaeoacremonium species (Calosphaeriales) exhibited distinct antifungal susceptibility patterns. Accurate identification of melanized fungi in clinical laboratories is essential for selecting effective antifungal therapy, understanding susceptibility patterns to available agents, supporting epidemiological monitoring, and ultimately enhancing clinical outcomes in patients affected by these often complex and opportunistic infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsFungiMycosesHumansRetrospective StudiesMicrobial Sensitivity TestsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMaleFemaleMiddle AgedAgedAdultDNA, Ribosomal SpacerUnited StatesDNA, FungalHospitalizationAged, 80 and over

Stichwörter der Autor:innen

antifungalsblack yeasts and their relativeshospitalized patientsmelanized fungirespiratory tract

Substanzen

Antifungal AgentsDNA, Ribosomal SpacerDNA, Fungal

Autor:innen und Institutionen

  • National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina.
  • Unidad de Parasitología, Sector Micología, Hospital JM Ramos Mejia, Buenos Aires, Argentina.
  • Foundation Atlas of Clinical Fungi, Hilversum, The Netherlands.
  • RadboudUMC/CWZ Center for Expertise in Mycology, Nijmegen, The Netherlands.
  • Microbiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.

ORCID-Profile: Roxana G Vitale, Amir Seyedmousavi

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Vitale, R. G., de Hoog, S., Stock, F., Scudder, C., Shahegh, S. E., Aneke, C. I., Tolooe, A., Fennelly, K. P., Lionakis, M. S., Kwon-Chung, J., & Seyedmousavi, A. (2025). Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles. Medical Mycology. https://doi.org/10.1093/mmy/myaf072

Vancouver

Vitale RG, de Hoog S, Stock F, Scudder C, Shahegh SE, Aneke CI, et al. Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles. Medical Mycology. 2025. doi:10.1093/mmy/myaf072

BibTeX
@article{Vitale2025,
  author = {Vitale, Roxana G and de Hoog, Sybren and Stock, Frida and Scudder, Chelsea and Shahegh, Sherin E and Aneke, Chioma I and Tolooe, Ali and Fennelly, Kevin P and Lionakis, Michail S and Kwon-Chung, June and Seyedmousavi, Amir},
  title = {Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles},
  journal = {Medical Mycology},
  year = {2025},
  doi = {10.1093/mmy/myaf072}
}
Kostenlos starten →